192 related articles for article (PubMed ID: 22341409)
1. Comparison of imaging characteristics between hepatic benign regenerative nodules and hepatocellular carcinomas associated with Budd-Chiari syndrome by contrast enhanced ultrasound.
Zhang R; Qin S; Zhou Y; Song Y; Sun L
Eur J Radiol; 2012 Nov; 81(11):2984-9. PubMed ID: 22341409
[TBL] [Abstract][Full Text] [Related]
2. Benign hepatic nodules in Budd-Chiari syndrome: radiologic-pathologic correlation with emphasis on the central scar.
Maetani Y; Itoh K; Egawa H; Haga H; Sakurai T; Nishida N; Ametani F; Shibata T; Kubo T; Tanaka K; Konishi J
AJR Am J Roentgenol; 2002 Apr; 178(4):869-75. PubMed ID: 11906865
[TBL] [Abstract][Full Text] [Related]
3. Tumor-specific vascularization pattern of liver metastasis, hepatocellular carcinoma, hemangioma and focal nodular hyperplasia in the differential diagnosis of 1,349 liver lesions in contrast-enhanced ultrasound (CEUS).
Strobel D; Seitz K; Blank W; Schuler A; Dietrich CF; von Herbay A; Friedrich-Rust M; Bernatik T
Ultraschall Med; 2009 Aug; 30(4):376-82. PubMed ID: 19688669
[TBL] [Abstract][Full Text] [Related]
4. Differentiating malignant from benign thrombosis in hepatocellular carcinoma: contrast-enhanced ultrasound.
Raza SA; Jang HJ; Kim TK
Abdom Imaging; 2014 Feb; 39(1):153-61. PubMed ID: 24002440
[TBL] [Abstract][Full Text] [Related]
5. Budd-Chiari Syndrome and hepatic regenerative nodules: Magnetic resonance findings with emphasis of hepatobiliary phase.
Mamone G; Carollo V; Di Piazza A; Cortis K; Degiorgio S; Miraglia R
Eur J Radiol; 2019 Aug; 117():15-25. PubMed ID: 31307641
[TBL] [Abstract][Full Text] [Related]
6. Contrast-enhanced ultrasound of hepatocarcinogenesis in liver cirrhosis.
Wu W; Chen MH; Sun M; Yan K; Yang W; Li JY
Chin Med J (Engl); 2012 Sep; 125(17):3104-9. PubMed ID: 22932189
[TBL] [Abstract][Full Text] [Related]
7. Low specificity of washout to diagnose hepatocellular carcinoma in nodules showing arterial hyperenhancement in patients with Budd-Chiari syndrome.
Van Wettere M; Purcell Y; Bruno O; Payancé A; Plessier A; Rautou PE; Cazals-Hatem D; Valla D; Vilgrain V; Ronot M
J Hepatol; 2019 Jun; 70(6):1123-1132. PubMed ID: 30654065
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular nodules in liver cirrhosis: contrast-enhanced ultrasound.
Kim TK; Lee KH; Khalili K; Jang HJ
Abdom Imaging; 2011 Jun; 36(3):244-63. PubMed ID: 21253723
[TBL] [Abstract][Full Text] [Related]
9. Value of wash-in and wash-out time in the diagnosis between hepatocellular carcinoma and other hepatic nodules with similar vascular pattern on contrast-enhanced ultrasound.
Kong WT; Wang WP; Huang BJ; Ding H; Mao F
J Gastroenterol Hepatol; 2014 Mar; 29(3):576-80. PubMed ID: 24118042
[TBL] [Abstract][Full Text] [Related]
10. Lack of arterial hypervascularity at contrast-enhanced ultrasound should not define the priority for diagnostic work-up of nodules <2 cm.
Forner A; Vilana R; Bianchi L; Rodríguez-Lope C; Reig M; García-Criado MÁ; Rimola J; Solé M; Ayuso C; Bru C; Bruix J
J Hepatol; 2015 Jan; 62(1):150-5. PubMed ID: 25173969
[TBL] [Abstract][Full Text] [Related]
11. Sonographic characterisation of hepatocellular carcinoma at time of diagnosis.
Ignee A; Weiper D; Schuessler G; Teuber G; Faust D; Dietrich CF
Z Gastroenterol; 2005 Mar; 43(3):289-94. PubMed ID: 15765302
[TBL] [Abstract][Full Text] [Related]
12. Differential patterns of contrast enhancement in different focal liver lesions after injection of the microbubble US contrast agent SonoVue.
Quaia E; Degobbis F; Tona G; Mosconi E; Bertolotto M; Pozzi Mucelli R
Radiol Med; 2004 Mar; 107(3):155-65. PubMed ID: 15031681
[TBL] [Abstract][Full Text] [Related]
13. Contrast enhanced ultrasound for the characterization of hepatocellular carcinoma.
Martie A; Sporea I; Popescu A; Sirli R; Dănilă M; Serban C; Ardelean M; Bota S; Sendroiu M; Chisevescu D
Med Ultrason; 2011 Jun; 13(2):108-13. PubMed ID: 21655536
[TBL] [Abstract][Full Text] [Related]
14. Hepatic nodules in Budd-Chiari syndrome: imaging features.
Vilgrain V; Lewin M; Vons C; Denys A; Valla D; Flejou JF; Belghiti J; Menu Y
Radiology; 1999 Feb; 210(2):443-50. PubMed ID: 10207428
[TBL] [Abstract][Full Text] [Related]
15. Evidence of diagnostic enhancement pattern in hepatocellular carcinoma nodules ≤2 cm according to the AASLD/EASL revised criteria.
Quaia E; De Paoli L; Angileri R; Pizzolato R; Cabibbo B; Cova MA
Abdom Imaging; 2013 Dec; 38(6):1245-53. PubMed ID: 24026173
[TBL] [Abstract][Full Text] [Related]
16. Contrast-enhanced MR angiography of benign regenerative nodules following TIPS shunt procedure in Budd-Chiari syndrome.
Tanju S; Erden A; Ceyhan K; Soygür IT; Bozkaya H; Erden I
Turk J Gastroenterol; 2004 Sep; 15(3):173-7. PubMed ID: 15492917
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in Budd-Chiari syndrome: enhancement patterns at dynamic gadolinium-enhanced T1-weighted MR imaging.
Yang C; Xu K; Zheng J; Ma P; Hu C; Li S; Rong Y; Lu X; Zhang Q; Zu M; Hua R; Zhang L
Cell Biochem Biophys; 2014 Sep; 70(1):661-6. PubMed ID: 24760630
[TBL] [Abstract][Full Text] [Related]
18. Radiological study of idiopathic Budd-Chiari syndrome complicated by hepatocellular carcinoma. A report of four cases.
Takayasu K; Muramatsu Y; Moriyama N; Wakao F; Makuuchi M; Takayama T; Kosuge T; Okazaki N; Yamada R
Am J Gastroenterol; 1994 Feb; 89(2):249-53. PubMed ID: 8304312
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular nodules expressing markers of hepatocellular adenomas in Budd-Chiari syndrome and other rare hepatic vascular disorders.
Sempoux C; Paradis V; Komuta M; Wee A; Calderaro J; Balabaud C; Quaglia A; Bioulac-Sage P
J Hepatol; 2015 Nov; 63(5):1173-80. PubMed ID: 26119687
[TBL] [Abstract][Full Text] [Related]
20. Characterization of primary and recurrent nodules in liver cirrhosis using contrast-enhanced ultrasound: which vascular criteria should be adopted?
Leoni S; Piscaglia F; Granito A; Borghi A; Galassi M; Marinelli S; Terzi E; Bolondi L
Ultraschall Med; 2013 Jun; 34(3):280-7. PubMed ID: 23616066
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
